BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21078882)

  • 1. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
    Smedley RC; Lamoureux J; Sledge DG; Kiupel M
    Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of routine cytology and immunocytochemistry in preoperative diagnosis of oral amelanotic melanomas in dogs.
    Przeździecki R; Czopowicz M; Sapierzyński R
    Vet Clin Pathol; 2015 Dec; 44(4):597-604. PubMed ID: 26398102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical identification of canine melanocytic neoplasms with antibodies to melanocytic antigen PNL2 and tyrosinase: comparison with Melan A.
    Ramos-Vara JA; Miller MA
    Vet Pathol; 2011 Mar; 48(2):443-50. PubMed ID: 20858741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.
    Choi C; Kusewitt DF
    Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Expression of
    Tsoi MF; Thaiwong T; Smedley RC; Noland E; Kiupel M
    Front Vet Sci; 2021; 8():701457. PubMed ID: 34422947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections.
    Kaufmann O; Koch S; Burghardt J; Audring H; Dietel M
    Mod Pathol; 1998 Aug; 11(8):740-6. PubMed ID: 9720502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
    Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
    Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
    J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck.
    Morris LG; Wen YH; Nonaka D; DeLacure MD; Kutler DI; Huan Y; Wang BY
    Head Neck; 2008 Jun; 30(6):771-5. PubMed ID: 18228523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
    Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
    Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An osteoid variant of cutaneous melanoma in a dog detected by S100 and melan a markers.
    Maliver P; Estrada M; Lagadic M; Mialot M; Manin S; Fontaine JJ
    J Vet Med A Physiol Pathol Clin Med; 2004 Dec; 51(9-10):413-5. PubMed ID: 15610483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
    Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
    J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Prognosis of Canine Melanocytic Neoplasms.
    Smedley RC; Sebastian K; Kiupel M
    Vet Sci; 2022 Apr; 9(4):. PubMed ID: 35448673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
    Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
    Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.
    Teixeira TF; Gentile LB; da Silva TC; Mennecier G; Chaible LM; Cogliati B; Roman MA; Gioso MA; Dagli ML
    Vet Res Commun; 2014 Mar; 38(1):29-38. PubMed ID: 24126842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of melanocytic antigen PNL2, Melan A, S100, and PGP 9.5 in equine melanocytic neoplasms.
    Ramos-Vara JA; Frank CB; DuSold D; Miller MA
    Vet Pathol; 2014 Jan; 51(1):161-6. PubMed ID: 23370093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.
    Orlow SJ; Silvers WK; Zhou BK; Mintz B
    Cancer Res; 1998 Apr; 58(7):1521-3. PubMed ID: 9537258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BILATERALLY SYMMETRICAL ORAL AMELANOTIC MELANOMA IN A BOA CONSTRICTOR (BOA CONSTRICTOR CONSTRICTOR).
    Thompson KA; Campbell M; Levens G; Agnew D
    J Zoo Wildl Med; 2015 Sep; 46(3):629-32. PubMed ID: 26352976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.